ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Using Three Methods To Encourage Grants In Programs

August 25, 1978

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

With workload Up, Oncology Division To Add More Staff

August 2, 1996

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992